Global Antibody Fragments Market Research Report 2021
Table of Contents1 Antibody Fragments Market Overview
1.1 Product Overview and Scope of Antibody Fragments
1.2 Antibody Fragments Segment by Type
1.2.1 Global Antibody Fragments Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 F(ab) Fragment
1.2.3 F(ab')2 Fragment
1.3 Antibody Fragments Segment by Application
1.3.1 Antibody Fragments Sales Comparison by Application: (2021-2027)
1.3.2 Cancer
1.3.3 Immunodeficiencies
1.3.4 Other
1.4 Global Antibody Fragments Market Size Estimates and Forecasts
1.4.1 Global Antibody Fragments Revenue 2016-2027
1.4.2 Global Antibody Fragments Sales 2016-2027
1.4.3 Antibody Fragments Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibody Fragments Market Competition by Manufacturers
2.1 Global Antibody Fragments Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Fragments Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Fragments Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Fragments Manufacturing Sites, Area Served, Product Type
2.5 Antibody Fragments Market Competitive Situation and Trends
2.5.1 Antibody Fragments Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody Fragments Players Market Share by Revenue
2.5.3 Global Antibody Fragments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody Fragments Retrospective Market Scenario by Region
3.1 Global Antibody Fragments Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Antibody Fragments Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Antibody Fragments Market Facts & Figures by Country
3.3.1 North America Antibody Fragments Sales by Country
3.3.2 North America Antibody Fragments Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody Fragments Market Facts & Figures by Country
3.4.1 Europe Antibody Fragments Sales by Country
3.4.2 Europe Antibody Fragments Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody Fragments Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody Fragments Sales by Region
3.5.2 Asia Pacific Antibody Fragments Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody Fragments Market Facts & Figures by Country
3.6.1 Latin America Antibody Fragments Sales by Country
3.6.2 Latin America Antibody Fragments Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody Fragments Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody Fragments Sales by Country
3.7.2 Middle East and Africa Antibody Fragments Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody Fragments Historic Market Analysis by Type
4.1 Global Antibody Fragments Sales Market Share by Type (2016-2021)
4.2 Global Antibody Fragments Revenue Market Share by Type (2016-2021)
4.3 Global Antibody Fragments Price by Type (2016-2021)
5 Global Antibody Fragments Historic Market Analysis by Application
5.1 Global Antibody Fragments Sales Market Share by Application (2016-2021)
5.2 Global Antibody Fragments Revenue Market Share by Application (2016-2021)
5.3 Global Antibody Fragments Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.2.4 F. Hoffmann-La Roche Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amgen Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bristol-Myers Squibb Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AbbVie Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Pharmaceutical Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Biogen
6.9.1 Biogen Corporation Information
6.9.2 Biogen Description and Business Overview
6.9.3 Biogen Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Biogen Product Portfolio
6.9.5 Biogen Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Antibody Fragments Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Eli Lilly Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
7 Antibody Fragments Manufacturing Cost Analysis
7.1 Antibody Fragments Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody Fragments
7.4 Antibody Fragments Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody Fragments Distributors List
8.3 Antibody Fragments Customers
9 Antibody Fragments Market Dynamics
9.1 Antibody Fragments Industry Trends
9.2 Antibody Fragments Growth Drivers
9.3 Antibody Fragments Market Challenges
9.4 Antibody Fragments Market Restraints
10 Global Market Forecast
10.1 Antibody Fragments Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody Fragments by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody Fragments by Type (2022-2027)
10.2 Antibody Fragments Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody Fragments by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody Fragments by Application (2022-2027)
10.3 Antibody Fragments Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody Fragments by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody Fragments by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Antibody Fragments Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibody Fragments Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Antibody Fragments Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibody Fragments Covered in This Study
Table 5. Global Antibody Fragments Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Antibody Fragments Sales Share by Manufacturers (2016-2021)
Table 7. Global Antibody Fragments Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibody Fragments Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibody Fragments Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibody Fragments Manufacturing Sites and Area Served
Table 11. Manufacturers Antibody Fragments Product Type
Table 12. Global Antibody Fragments Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody Fragments by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Fragments as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibody Fragments Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Antibody Fragments Sales Market Share by Region (2016-2021)
Table 17. Global Antibody Fragments Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibody Fragments Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Antibody Fragments Sales Market Share by Country (2016-2021)
Table 20. North America Antibody Fragments Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibody Fragments Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibody Fragments Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Antibody Fragments Sales Market Share by Country (2016-2021)
Table 24. Europe Antibody Fragments Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibody Fragments Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibody Fragments Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Antibody Fragments Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibody Fragments Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibody Fragments Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibody Fragments Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Antibody Fragments Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibody Fragments Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibody Fragments Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibody Fragments Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Antibody Fragments Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibody Fragments Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibody Fragments Revenue Market Share by Country (2016-2021)
Table 38. Global Antibody Fragments Sales (K Pcs) by Type (2016-2021)
Table 39. Global Antibody Fragments Sales Market Share by Type (2016-2021)
Table 40. Global Antibody Fragments Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibody Fragments Revenue Share by Type (2016-2021)
Table 42. Global Antibody Fragments Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Antibody Fragments Sales (K Pcs) by Application (2016-2021)
Table 44. Global Antibody Fragments Sales Market Share by Application (2016-2021)
Table 45. Global Antibody Fragments Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibody Fragments Revenue Share by Application (2016-2021)
Table 47. Global Antibody Fragments Price (USD/Pcs) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Novartis Antibody Fragments Product
Table 52. Novartis Recent Developments/Updates
Table 53. F. Hoffmann-La Roche Corporation Information
Table 54. F. Hoffmann-La Roche Description and Business Overview
Table 55. F. Hoffmann-La Roche Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. F. Hoffmann-La Roche Antibody Fragments Product
Table 57. F. Hoffmann-La Roche Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Antibody Fragments Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Amgen Corporation Information
Table 64. Amgen Description and Business Overview
Table 65. Amgen Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Amgen Antibody Fragments Product
Table 67. Amgen Recent Developments/Updates
Table 68. Bristol-Myers Squibb Corporation Information
Table 69. Bristol-Myers Squibb Description and Business Overview
Table 70. Bristol-Myers Squibb Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Bristol-Myers Squibb Antibody Fragments Product
Table 72. Bristol-Myers Squibb Recent Developments/Updates
Table 73. AbbVie Corporation Information
Table 74. AbbVie Description and Business Overview
Table 75. AbbVie Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. AbbVie Antibody Fragments Product
Table 77. AbbVie Recent Developments/Updates
Table 78. Takeda Pharmaceutical Corporation Information
Table 79. Takeda Pharmaceutical Description and Business Overview
Table 80. Takeda Pharmaceutical Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Takeda Pharmaceutical Antibody Fragments Product
Table 82. Takeda Pharmaceutical Recent Developments/Updates
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Sanofi Antibody Fragments Product
Table 87. Sanofi Recent Developments/Updates
Table 88. Biogen Corporation Information
Table 89. Biogen Description and Business Overview
Table 90. Biogen Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Biogen Antibody Fragments Product
Table 92. Biogen Recent Developments/Updates
Table 93. Eli Lilly Corporation Information
Table 94. Eli Lilly Description and Business Overview
Table 95. Eli Lilly Antibody Fragments Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Eli Lilly Antibody Fragments Product
Table 97. Eli Lilly Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Antibody Fragments Distributors List
Table 101. Antibody Fragments Customers List
Table 102. Antibody Fragments Market Trends
Table 103. Antibody Fragments Growth Drivers
Table 104. Antibody Fragments Market Restraints
Table 105. Global Antibody Fragments Sales Forecast by Type (2022-2027) & (K Pcs)
Table 106. Global Antibody Fragments Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Antibody Fragments Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Antibody Fragments Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Antibody Fragments Sales Forecast by Application (2022-2027) & (K Pcs)
Table 110. Global Antibody Fragments Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Antibody Fragments Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Antibody Fragments Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Antibody Fragments Sales Forecast by Region (2022-2027) & (K Pcs)
Table 114. Global Antibody Fragments Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Antibody Fragments Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Antibody Fragments Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Antibody Fragments
Figure 2. Global Antibody Fragments Market Share by Type in 2020 & 2027
Figure 3. F(ab) Fragment Product Picture
Figure 4. F(ab')2 Fragment Product Picture
Figure 5. Global Antibody Fragments Market Share by Application in 2020 & 2027
Figure 6. Cancer
Figure 7. Immunodeficiencies
Figure 8. Other
Figure 9. Global Antibody Fragments Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Antibody Fragments Market Size 2016-2027 (US$ Million)
Figure 11. Global Antibody Fragments Sales 2016-2027 (K Pcs)
Figure 12. Global Antibody Fragments Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Antibody Fragments Sales Share by Manufacturers in 2020
Figure 14. Global Antibody Fragments Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Antibody Fragments Players: Market Share by Revenue in 2020
Figure 16. Antibody Fragments Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Antibody Fragments Sales Market Share by Region (2016-2021)
Figure 18. Global Antibody Fragments Sales Market Share by Region in 2020
Figure 19. Global Antibody Fragments Revenue Market Share by Region (2016-2021)
Figure 20. Global Antibody Fragments Revenue Market Share by Region in 2020
Figure 21. U.S. Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Antibody Fragments Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Antibody Fragments by Type (2016-2021)
Figure 46. Sales Market Share of Antibody Fragments by Application (2016-2021)
Figure 47. Sales Market Share of Antibody Fragments by Application in 2020
Figure 48. Revenue Share of Antibody Fragments by Application (2016-2021)
Figure 49. Revenue Share of Antibody Fragments by Application in 2020
Figure 50. Manufacturing Cost Structure of Antibody Fragments
Figure 51. Manufacturing Process Analysis of Antibody Fragments
Figure 52. Antibody Fragments Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed